According to Market Research Future, the Global 3D Cell Culture Marketto provide readers with a clear view of the market’s likely growth trajectory over the coming years. The report utilizes historical trends of the Global 3D Cell Culture Market and present statistics to derive.
3D Cell Culture Market – Highlights
Global 3D Cell Culture Market that concludes the surge for this market at 25% CAGR (Compound Annual Growth Rate) between 2017 and 2023. There is no break to the impressive developments being accomplished by medical science. The tissue regeneration technology has enabled the growth and repair of cells in the human body. The 3D cell culture technique helps biological cells to grow or interact with their surroundings in all three dimensions. As 3D cell culture provides more authentic data and more physiologically admissible information in vivo tests, it has become acceptable in comparison to 2D Cell culture.
The key factors pushing the growth of the global 3D cell culture market include organ and tissue regeneration capability and providing drug toxicology screening. Other factors supporting the market growth of this market include growing awareness, increasing the incidence of cancer, increasing prevalence of organ failures, demand for organ transplant, rising approval from government bodies, rising demand for organs transplantation, rising prevalence of cancer worldwide, and lastly the varying applications of 3D cell culture in biotech and pharmaceutical industry.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/5928
The key players in the global 3D cell culture market include Becton-Dickinson and Company (USA), Corning Incorporated (USA), Charles River Laboratories Inc (USA), InSphero, AG (Switzerland), The Electrospinning Company (UK), Kuraray Co Ltd (Japan), Lena Biosciences Inc. (USA), Lonza (Switzerland), Tecan Trading AG (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (USA) and ReproCELL Europe Ltd (UK).
Latest Industry News:
- As the leader in 3D cell culture characterization and analysis, Visikol is now expanding their service by introducing its own liver 3D cell culture models. 16 JAN 2019
- La Tronche-based Manufacturer of 3D microprinting machines for industrial and scientific applications, Microlight3D, has launched Altraspin, a compact 3D printer intended for producing highly complex micro-parts with sub-micron resolution. It is suited to cell culture, metamaterials, micromechanics, microrobotics, surface structuration, and tissue engineering. 22 JAN 2019
The global 3D cell culture market has been segmented into the end user, application, technique, product, and lastly region. Based on end users, this market has been segmented into pharmaceutical & biotechnology companies, contract research organizations, research & academic laboratories and others. Contract research organizations offer support to the medical device, biotechnology, and pharmaceutical industries in the form of research services outsourced on a contract basis. During the forecast period, the Pharmaceutical & Biotechnology Companies (as one segment) is expected to witness maximum growth with the CAGR of 26.13%.
According to the application-based segmentation, the market has been segmented into drug discovery, cancer research, stem cell research, regenerative medicine, tissue screening & engineering, and others. Drug discovery is a process helpful to the researchers regarding the discovery of new candidate medications. During the forecast period, among application segments, drug discovery is expected to emerge as the largest segment with 25.75% CAGR. Regenerative medicine can be described as a branch of translational research in tissue engineering and molecular biology. It deals with the process to replace, engineer or regenerate tissues, human cells, or organs in order to restore or establish normal function. Stem cell research is defined as the process of borrowing cells from developed organs of the body and used for repairing unhealthy organs. The tissue engineering assembles the functional constructs that heel, maintain and restore the damaged tissues or whole organs.
In the context of technique, the market segmentation covers scaffolds-based 3D cell culture and scaffold-free 3D cell culture. The cells from the body are combined with highly porous scaffold biomaterials. These biomaterials act as templates for tissue regeneration in order to guide the growth of new tissue. This helps to develop the field of tissue engineering in order to regenerate damaged tissues. Scaffold-based 3D cell culture has been segmented into hydrogel-based support and polymeric hard material-based support. Scaffold-Free 3D Cell Culture has been sub-segmented into hanging drop microplates, low adhesion plates, microfluidic 3D cell culture, rotating bioreactors, magnetic 3D bioprinting, micropatterned surfaces, magnetic levitation, spheroid microplates containing Ultra-Low Attachment (ULA) coating.
Regarding products, the market has been segmented into consumables and instruments. Consumables segment includes products like cotton buds, cleaning materials, vials, plastic funnels, etc. Instruments segment includes devices that are used for surgeries and activities like removing the tumor. During the forecast period, consumables have been estimated to witness the highest growth with a CAGR of 25.88%.
The regional segmentation of the global 3D cell culture market segments the global market into regional markets namely The Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA). In North America, the market is strong due to many key players based in the USA, availability of advanced medical facilities, and the availability of advanced technology. Due to technology, North America is a bigger market than South America. In North America, after the USA, Canada is the biggest economy. In South America, Argentina and Brazil are two strong economies that can be suitable markets in the future.
Browse Complete 100 Pages Premium Research Report Enabled with 200+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/3d-cell-culture-market-5928
In Europe, due to reasons same as The Americas, Western Europe is a bigger market than Eastern Europe. The strongest economies in Europe are France, Germany, and the UK.
In the MEA region, the market is small due to the lack of technological advancement, most governments not considering healthcare a priority, and lawless environment due to events like the Arab Spring. Some countries in this region do have a modest level of technological advancement and doctors with modern education because of which, they can be suitable markets. Such countries are Oman, Kuwait, Saudi Arabia, Qatar, and UAE, followed by the remaining countries of the MEA region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312